xncsansncsiocndoiwhfiewiwejifq'weoqwemf;ewhqenfeuioniueoqey
Answer: 96040, Q99.2 are the codes for CPT and ICD-10-CM respectively.
Explanation:
Fragile X syndrome, also known as Martin-Bell syndrome is a genetic condition which causes developmental problems including cognitive impairment and intellectual disabilites especially among boys.
Individuals affected usually have delayed development of speech and language by age 2.
Q99.2 is a billable ICD code detailed enough for the diagnosis of fragile X chromosome. So in the ICD-10-CM Alphabetic Index , we look for Fragile X which takes us to Q99.2.
The Current Procedural Terminology (CPT) code for Fragile X syndrome as maintained by American Medical Association, is 96040. This is a medical procedural code under the range of Medical Genetics and Genetic Counseling services.
Answer:
Drugs are labeled to unequivocally determinate their drug/pharmaceutical compounds, doses, declared strength and prospects, thereby giving to the patient concise data that ensure a correct medication.
The errors occurred during drug labeling may be due to professional negligence or errors in the print process. Regardless the cause, these errors must be immediately communicated to the competent government organisms (such as for instance, the Food and Drug Administration in the US), and the public in general, it in order to avoid damages to the patients that could be occasioned by its use. Error reporting should be considered to be independent of economical issues and pharmaceutical commercial interests because it can save lives and improve patient safety, which are the first objectives to be pursued by drug manufacturers.
Moreover, it is important to note that the ISMP National Medication Errors Reporting Program (ISMP MERP) is an organization program that enables professionals working in health care institutions to report any labeling error.
